Cargando…

Clinical trials may be unethical in certain instances

After review of the literature, I conclude that clinical trials may be unethical.

Detalles Bibliográficos
Autor principal:	Kostis, John B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Hypertension Highlights
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803080/ https://www.ncbi.nlm.nih.gov/pubmed/33447778 http://dx.doi.org/10.1016/j.ijchy.2020.100057

Ejemplares similares

Telemedicine can revolutionize the treatment of chronic disease
por: Corbett, Jeffrey A., et al.
Publicado: (2020)

Hypothesis: Unrecognized actions of ENaC blockade in improving refractory-resistant hypertension and residual cardiovascular risk
por: Elijovich, Fernando, et al.
Publicado: (2020)

Cardiovascular medications and regulation of COVID-19 receptors expression
por: Saheb Sharif-Askari, Narjes, et al.
Publicado: (2020)

Most Recent Trials and Advances in Hypertension
por: Rey-Rañal, Elías Martínez, et al.
Publicado: (2022)

The Role of Nocturnal Blood Pressure and Sleep Quality in Hypertension Management
por: Cappuccio, Francesco P
Publicado: (2020)

The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg
por: Schrader, J, et al.
Publicado: (2009)

Endothelial Dysfunction in Diabetes: The role of reparatory mechanisms
por: Avogaro, Angelo, et al.
Publicado: (2011)

Endothelial Factors and Diabetic Nephropathy
por: Karalliedde, Janaka, et al.
Publicado: (2011)

Benefits of Tight Blood Pressure Control in Diabetic Patients With Hypertension: Importance of early and sustained implementation of effective treatment strategies
por: Parati, Gianfranco, et al.
Publicado: (2011)

Antihypertensive Treatment and Blood Pressure in Diabetic and Nondiabetic Patients: The lower, the better?
por: Mancia, Giuseppe, et al.
Publicado: (2011)

Blood Pressure: The Lower, the Better: The con side
por: Grossman, Ehud
Publicado: (2011)

Diuretic Treatment of Hypertension
por: Grossman, Ehud, et al.
Publicado: (2011)

RAS Blockade for Every Diabetic Patient: Pro and Con
por: Ruilope, Luis M., et al.
Publicado: (2011)

Monitoring Kidney Function and Albuminuria in Patients With Diabetes
por: Lambers Heerspink, Hiddo J., et al.
Publicado: (2011)

Limitations and Future Treatment Options in Type 2 Diabetes With Renal Impairment
por: Ritz, Eberhard
Publicado: (2011)

Individualization of Antihypertensive Drug Treatment
por: Mancia, Giuseppe, et al.
Publicado: (2013)

Intolerance to Statins: Mechanisms and Management
por: Bitzur, Rafael, et al.
Publicado: (2013)

Prognostic Value of Blood Pressure Variability and Average Blood Pressure Levels in Patients With Hypertension and Diabetes
por: Parati, Gianfranco, et al.
Publicado: (2013)

Ambulatory Blood Pressure Monitoring in the Diagnosis and Management of Hypertension
por: Grossman, Ehud
Publicado: (2013)

Familial history of hypertension as a predictor of increased arterial stiffness in normotensive offspring
por: Youssef, Ghada, et al.
Publicado: (2017)

Use of machine-learning algorithms to determine features of systolic blood pressure variability that predict poor outcomes in hypertensive patients
por: Lacson, Ronilda C, et al.
Publicado: (2018)

The chaos of hypertension guidelines for chronic kidney disease patients
por: Castillo-Rodriguez, Esmeralda, et al.
Publicado: (2019)

(Pro)renin Receptor and Blood Pressure Regulation: A Focus on the Central Nervous System
por: Souza, Lucas A.C., et al.
Publicado: (2022)

Hypertension : physiopathology and treatment /
Publicado: (1977)

Uses and opportunities for machine learning in hypertension research
por: Amaratunga, Dhammika, et al.
Publicado: (2020)

Unethical Conduct of Underpowered Clinical Trials
por: Habibzadeh, Farrokh
Publicado: (2013)

Unregistered Trials Are Unethical
por: Krishnan, Eswar
Publicado: (2005)

Clinical characteristics and outcomes of Chinese patients with coronary heart disease and resistant hypertension
por: Zhu, Binbin, et al.
Publicado: (2023)

Evaluation of the angiotensin II receptor blocker azilsartan medoxomil in African‐American patients with hypertension
por: Johnson, Wallace, et al.
Publicado: (2017)

Identifying Patients with Group 3 Pulmonary Hypertension Associated with COPD or ILD Using an Administrative Claims Database
por: Heresi, Gustavo A., et al.
Publicado: (2022)

Hypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients
por: van Dorst, Daan C.H., et al.
Publicado: (2021)

Unethical Advertisements
Publicado: (1878)

Hypertension Management in Emergency Departments
por: Miller, Joseph, et al.
Publicado: (2020)

Characterizing the Latent HIV-1 Reservoir in Patients with Viremia Suppressed on cART: Progress, Challenges, and Opportunities
por: Rausch, Jason W., et al.
Publicado: (2020)

Association of pulse wave velocity and intima‐media thickness with cardiovascular risk factors in young adults
por: Cecelja, Marina, et al.
Publicado: (2020)

Pulmonary Hypertension in Heart Failure Patients
por: Rao, Sriram D, et al.
Publicado: (2020)

Can a New Scoring System Improve Prediction of Pulmonary Hypertension in Newly Recognised Interstitial Lung Diseases?
por: Sobiecka, Małgorzata, et al.
Publicado: (2020)

Potential benefits and harms of various arterial hypertension guidelines
por: Dorobantu, Maria, et al.
Publicado: (2020)

Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension
por: Leeming, D J, et al.
Publicado: (2013)

Lower is better in hypertension, but how low should blood pressure be targeted?
por: Touyz, Rhian M.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4pgome387vqlamo1dnj4sjtmn7